TR100 is a first-in-class compound anti-tropomyosin (ATM), targeting tropomyosin isoform, Tpm3.1. References: Kee AJ, Chagan J, Chan JY, Bryce NS, Lucas CA, Zeng J, Hook J, Treutlein H, Laybutt DR, Stehn JR, Gunning PW, Hardeman EC. On-target action of anti-tropomyosin drugs regulates glucose metabolism. Sci Rep. 2018 Mar 15;8(1):4604. doi: 10.1038/s41598-018-22946-x. PubMed PMID: 29545590; PubMed Central PMCID: PMC5854615.

纯度：≥98%

CAS：1128165-86-5